Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06004739 · ClinicalTrials.gov registry record · NA
Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection
A NA study of Infectious Disease, sponsored by Mount Sinai Hospital, Canada.
- Recruiting
- Registry status
- NA
- Development phase
- 550
- Enrollment target
- 7
- Study locations
NCT06004739 is a NA study of Infectious Disease that is actively recruiting participants, run by Mount Sinai Hospital, Canada. The registered enrollment target is 550 participants, below the 6,994-participant average among 18 other Infectious Disease trials with a reported enrollment target (92% lower). The trial reports 7 study locations across 2 states.
The verdict
NCT06004739, a NA study of Infectious Disease, is actively recruiting participants, sponsored by Mount Sinai Hospital, Canada.
- RECRUITING
- Registry status
- NA
- Development phase
- 550 participants
- Enrollment target
- 7
- Study locations
Study Summary
Delirium is an acute confusional state that is experienced by many older adults who are admitted to hospital. To treat delirium the underlying cause needs to be identified promptly, but this is challenging. One of the potential causes of delirium is infection. Urine tests show that most patients experiencing delirium have bacteria in their urine, however, bacteria in the urine is common among older adults, and does not automatically indicate an infection is present. As a result it is difficult to know whether a lower urinary tract infection is present as individuals with delirium are frequently unable to report clinical signs of infection - symptoms of pain or discomfort with urination, having to urinate more frequently or pelvic discomfort. Very often, individuals with delirium are treated with antibiotics despite the fact that it is unknown whether antibiotics help to improve delirium in cases where bacteria in the urine is present. This proposed study is a randomized controlled trial that will examine if adults (age 60 or older) with delirium and suspected infection benefit from taking antibiotics.
Conditions Studied
Interventions
- DRUG Start Antibiotics / Continue Antibiotics for treatment of bacteriuria
- OTHER No Antibiotics for treatment of bacteriuria
Study Locations (7)
Other
- The Ottawa Hospital Civic Campus - Ottawa
- The Ottawa Hospital General Campus - Ottawa
- Hennick Bridgepoint Hospital - Toronto
- Michael Garron Hospital - Toronto
- Mount Sinai Hospital - Toronto
- Toronto General Hospital - Toronto
Illinois
- Northwestern Memorial Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2024-05-18 |
| Est. Completion | 2027-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06004739
The ClinicalTrials.gov registry entry for NCT06004739 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,994-participant average among 18 other Infectious Disease trials with a reported enrollment target (92% lower). The listed sponsor is Mount Sinai Hospital, Canada, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infectious Disease appearing as the primary indexed condition, and to 2 interventions - of which Start Antibiotics / Continue Antibiotics for treatment of bacteriuria is the first listed.
NCT06004739 reports 7 study locations spanning 2 distinct geographic areas - top geographies include Other, Illinois.
Frequently Asked Questions
What is clinical trial NCT06004739 about?
NCT06004739 is a clinical study titled "Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection". Delirium is an acute confusional state that is experienced by many older adults who are admitted to hospital. To treat delirium the underlying cause needs to be identified promptly, but this is challenging. One of the potential causes of delirium is infection. Urine tests show that most patients exp...
What is the current status of trial NCT06004739?
This trial is currently recruiting. It is a NA study. The enrollment target is 550 participants. The study started on 2024-05-18. Estimated completion is 2027-09.
What conditions does trial NCT06004739 study?
This clinical trial studies the following conditions: Infectious Disease.
What interventions are being tested in trial NCT06004739?
The interventions under investigation include: Start Antibiotics / Continue Antibiotics for treatment of bacteriuria (DRUG), No Antibiotics for treatment of bacteriuria (OTHER).
Who is sponsoring clinical trial NCT06004739?
This trial is sponsored by Mount Sinai Hospital, Canada, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06004739 being conducted?
This trial has 7 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infectious Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing
RECRUITING · NA
-
A Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk Monitor
ACTIVE NOT RECRUITING · NA
-
Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations
ACTIVE NOT RECRUITING · NA
-
Minnesota COVID-19 Testing Project
COMPLETED · NA
-
Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds
COMPLETED · NA
-
Clinical Decision Support Tools for Antibiotic Prescribing
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.